Search research articles
Contact Us
Filters
Showing results (71-80 of 233) with videos related to
Page
of 24
Sort By:
Leukemia Research
|
April 8, 2021
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT
Haris Ali, Amandeep Salhotra, Anthony S Stein, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 11, 2016
Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia
Monzr M Al Malki, Ibrahim Aldoss, Tracey Stiller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 6, 2015
Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Ibrahim Aldoss, Tracey Stiller, Thai M Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 6, 2016
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Ibrahim Aldoss, Ni-Chun Tsai, Marilyn L Slovak, et al.
Leukemia & Lymphoma
|
August 20, 2020
Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy
Tamer A Othman, Jianying Zhang, Matthew Mei, et al.
American Journal of Clinical Oncology
|
February 4, 2014
Effect of Surgical Intervention on Survival of Patients With Clinical N2 Non-Small Cell Lung Cancer: A Veterans' Affairs Central Cancer Registry (VACCR) Database Analysis
Apar K Ganti, Wilson Gonsalves, Fausto R Loberiza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 24, 2015
Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia
Ibrahim Aldoss, Monzr M Al Malki, Tracey Stiller, et al.
American Journal of Hematology
|
October 11, 2025
Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations
Ibrahim Aldoss, Amir Ali, Ryan D Cassaday, et al.
American Journal of Hematology
|
November 22, 2022
The feasibility of additional CD19-targeted cellular therapy in relapsed/refractory B-ALL with re-emergence of CD19 antigen after prior CD19-negative relapse
Vaibhav Agrawal, Amandeep Salhotra, Joo Song, et al.
Leukemia & Lymphoma
|
May 21, 2025
Comparison of CALGB 10403 and HyperCVAD in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia in adults ≥40 years old
Purav Mehta, Dat Ngo, Jose Tinajero, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 233) with videos related to
Sort By:
Page
of 24
Leukemia Research
|
April 8, 2021
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT
Haris Ali, Amandeep Salhotra, Anthony S Stein, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 11, 2016
Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia
Monzr M Al Malki, Ibrahim Aldoss, Tracey Stiller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 6, 2015
Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Ibrahim Aldoss, Tracey Stiller, Thai M Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 6, 2016
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Ibrahim Aldoss, Ni-Chun Tsai, Marilyn L Slovak, et al.
Leukemia & Lymphoma
|
August 20, 2020
Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy
Tamer A Othman, Jianying Zhang, Matthew Mei, et al.
American Journal of Clinical Oncology
|
February 4, 2014
Effect of Surgical Intervention on Survival of Patients With Clinical N2 Non-Small Cell Lung Cancer: A Veterans' Affairs Central Cancer Registry (VACCR) Database Analysis
Apar K Ganti, Wilson Gonsalves, Fausto R Loberiza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 24, 2015
Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia
Ibrahim Aldoss, Monzr M Al Malki, Tracey Stiller, et al.
American Journal of Hematology
|
October 11, 2025
Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations
Ibrahim Aldoss, Amir Ali, Ryan D Cassaday, et al.
American Journal of Hematology
|
November 22, 2022
The feasibility of additional CD19-targeted cellular therapy in relapsed/refractory B-ALL with re-emergence of CD19 antigen after prior CD19-negative relapse
Vaibhav Agrawal, Amandeep Salhotra, Joo Song, et al.
Leukemia & Lymphoma
|
May 21, 2025
Comparison of CALGB 10403 and HyperCVAD in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia in adults ≥40 years old
Purav Mehta, Dat Ngo, Jose Tinajero, et al.
Page
of 24